Health in Upper-middle income (World Bank) 149 indicators covering health for Upper-middle income (World Bank). IndicatorLatest Year10-yr change Rank Measles - number of reported cases 91,627 2025 up 3.0% 5th Diphtheria - number of reported cases 1,556 2025 up 1,327.5% 7th Total tetanus - number of reported cases 5,773 2025 up 208.1% 4th Pertussis - number of reported cases 63,803 2025 up 238.8% 4th Neonatal tetanus - number of reported cases 212 2025 down 60.8% 7th Underweight among adults, BMI < 18.5 kg/m2 (crude estimate) 4.0% 2024 down 27.0% 8th Overweight among adults, BMI ≥ 25 kg/m2 (crude estimate) 49.4% 2024 up 24.0% 5th Obesity among adults, BMI ≥ 30 kg/m2 (age-standardized estimate) 16.7% 2024 up 45.2% 5th Overweight among adults, BMI ≥ 25 kg/m2 (age-standardized estimate) 48.3% 2024 up 22.8% 5th Obesity among children and adolescents, BMI-for-age > +2 standard 16.7% 2024 up 50.6% 2nd Overweight among children and adolescents, BMI-for-age > +1 standard 31.6% 2024 up 26.8% 3rd Obesity among adults, BMI ≥ 30 kg/m2 (crude estimate) 16.9% 2024 up 45.4% 5th Underweight among adults, BMI < 18.5 kg/m2 (age-standardized estimate) 4.5% 2024 down 21.7% 8th Thinness among children and adolescents, BMI-for-age < -2 standard 4.0% 2024 down 11.3% 8th Number of infant deaths 315,969 2024 down 45.8% 7th Number of under-five deaths 384,951 2024 down 45.4% 7th Number of neonatal deaths 196,632 2024 down 46.2% 7th Under-five mortality rate 13.12 2024 down 22.3% 7th Infant mortality rate (probability of dying between birth and age 1) 10.9 2024 down 21.7% 8th Neonatal mortality rate 6.78 2024 down 21.7% 8th Adolescent mortality rate 1.37 2024 down 15.0% 8th Number of deaths among children ages 5 to 9 years 49,803 2024 down 23.6% 7th Mortality rate for 5-14 year-olds 2.65 2024 down 19.8% 7th Number of deaths among children 5 to 14 years of age 105,638 2024 down 15.9% 7th Number of deaths among adolescents 55,835 2024 down 7.5% 6th Mortality rate among children ages 5 to 9 years 1.27 2024 down 24.5% 7th Diabetes treatment coverage, age-standardized 44.35 2022 up 18.2% 4th Prevalence of diabetes, crude 13.52 2022 up 49.9% 6th Prevalence of diabetes, age-standardized 12.07 2022 up 35.6% 6th Diabetes treatment coverage, crude 45.31 2022 up 21.1% 4th Diphtheria tetanus toxoid and pertussis first-dose (DTP1) 91.0% 2025 down 4.2% 5th Measles-containing-vaccine second-dose (MCV2) immunization coverage 83.0% 2025 unchanged 5th Hepatitis B (HepB3) immunization coverage among 1-year-olds (%) 88.0% 2025 down 3.3% 5th Measles-containing-vaccine first-dose (MCV1) immunization coverage 89.0% 2025 down 5.3% 4th Diphtheria tetanus toxoid and pertussis third-dose (DTP3) 88.0% 2025 down 4.3% 5th Hib (Hib3) immunization coverage among 1-year-olds (%) 62.0% 2025 up 19.2% 10th Stunting prevalence among children under 5 years of age (%) 10.8% 2024 down 12.2% 32nd Stunting numbers among children under 5 years of age (millions) 16,768 2024 down 33.5% 18th Overweight prevalence among children under 5 years of age (%) 8.6% 2024 up 6.2% 15th Overweight numbers among children under 5 years of age (thousands) 13,265 2024 down 19.6% 5th Mean total cholesterol, age-standardized 4.7 2018 unchanged 3rd Mean Non-HDL cholesterol, crude 3.5 2018 up 2.9% 1st Mean HDL cholesterol, crude 1.2 2018 down 7.7% 4th Mean HDL cholesterol, age-standardized 1.2 2018 down 7.7% 4th Mean total cholesterol, crude 4.7 2018 up 2.2% 3rd Mean Non-HDL cholesterol, age-standardized 3.4 2018 unchanged 2nd BCG immunization coverage among 1-year-olds (%) 92.0% 2025 down 3.2% 3rd Number of incident tuberculosis cases 2.59 million 2024 down 12.2% 6th Incidence of tuberculosis 92 2024 down 16.4% 8th Number of incident tuberculosis cases 233,000 2024 down 50.5% 4th Number of deaths due to tuberculosis, excluding HIV 210,000 2024 up 2.4% 6th Deaths due to tuberculosis among HIV-negative people 7.4 2024 down 2.6% 8th Tuberculosis - new and relapse cases 1.98 million 2024 up 6.8% 5th Tuberculosis treatment coverage 76 2024 up 20.6% 6th Mean BMI (kg/m²) 25.1 2016 up 4.1% 5th Rubella - number of reported cases 3,728 2025 down 69.3% 5th Treatment success rate: new TB cases 84 2023 down 3.4% 8th Yellow fever - number of reported cases 303 2025 up 791.2% 3rd UHC Service Coverage sub-index on reproductive, maternal, newborn and 83 2023 unchanged 4th Stillbirth rate 6.91 2023 down 21.6% 7th Page 1 of 3 Next →